MSD reconfirms commitment to patients,health care system and economy in cyprus.MSD in Cyprus , a subsidiary of US based Merck & Co. Inc. Announced today that it has completed its integration in Cyprus with Schering-Plough Corporation. This development follows the recent worldwide announcement of Merck’s merger with Schering-Plough Corporation in November 2009. From the outset, MSD is a global health care leader with a diversified portfolio of prescription medicines, vaccines and animal and consumer health products. This portfolio is complemented by a robust pipeline with more than 15 promising late-stagecandidates spanning critical therapeutic categories.MSD now has approximately 100,000 employees, and operations in more than 140 countries around the world.
MSD’s commitment to Cyprus.
Cyprus is an integral part of the company’s expanded European and global presence.
MSD set up its local operations in 2005 i Nicosia. Since then, the company continuously expanded its presence on the island. Today, new MSD employs 36 highly qualified Cypriots. With the completion of the merger in Cyprus, MSD will now be responsible for marketing and promotion of the medicines and vaccines portfolio of MSD and former Schering-Plough Corporation to doctors and pharmacists all over the island and Malta as well as for the registration of these products in Cyprus. MSD products in Cyprus will continue to be distributed by the local distributor M.S. Lacovides & Co. Ltd (MSJ).
“MSD has had an excellent relationship with M.S.Jacovides for many years and the company is looking forward to continuing this relationship in the future”, says Anastassiades.
Related posts:
Tags: Economy, Economy in Cyprus, HEALTH, Healthcare, Healthcare Cyprus, Healthcare System, Healthcare system and economy in Cyprus, Inc, integration in Cyprus with Schering-Plough Corporation, MSD, MSD in Cyprus subsidiary of US based Merck & Co, MSD products in Cyprus will continue, MSD reconfirms committment, MSD will now be responsible for marketing, MSD's Commitment to Cyprus, promotion of the medicines and vaccines portfolio of MSD, US based Mercck & Co. Inc